Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers
November 6, 2018 8:34 AM
Nektar Therapeutics (NASDAQ: NKTR) announced that it has entered into an oncology clinical collaboration with Pfizer Inc. (NYSE: PFE) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
